Literature DB >> 7212740

Cutaneous manifestations of lymphomatoid granulomatosis. Report of 44 cases and a review of the literature.

W D James, R B Odom, A L Katzenstein.   

Abstract

A review of records of 44 patients who had lymphomatoid granulomatosis (LYG) with skin lesions showed that cutaneous manifestations are protean and generally transient. Subcutaneous or dermal nodules were present in more than 60% of cases. A maculopapular rash or macular erythema was less common, and ulceration was rare. Skin lesions were widely distributed. Frequently, in patients who had early cutaneous involvement with LYG, associated involvement of the nervous system and joints occurred. Findings from laboratory studies were generally inconclusive. Lymphomatoid granulomatosis progressed to lymphoma in 18% of the cases, and death from respiratory failure was common. Theories on the possible cause and the pathogenesis of LYG are presented.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7212740

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  5 in total

Review 1.  Pathobiology and treatment of lymphomatoid granulomatosis, a rare EBV-driven disorder.

Authors:  Christopher Melani; Elaine S Jaffe; Wyndham H Wilson
Journal:  Blood       Date:  2020-04-16       Impact factor: 22.113

2.  Lymphomatoid granulomatosis.

Authors:  C Harrington; M Wood; N Rooney; T Clark; J Maddocks; D Slater
Journal:  Br Med J (Clin Res Ed)       Date:  1983-05-28

3.  Erythrodermic lymphomatoid granulomatosis: a case report.

Authors:  Kaoru Imaoka; Minao Furumura; Riruke Maruyama; Ren Nagasako; Eishin Morita
Journal:  Case Rep Dermatol       Date:  2011-11-30

4.  A case of lymphomatoid granulomatosis presenting with cutaneous lesions.

Authors:  Sheila Shaigany; Nicole A Weitz; Sameera Husain; Larisa Geskin; Marc E Grossman
Journal:  JAAD Case Rep       Date:  2015-07-02

5.  A Literature Revision in Primary Cutaneous B-cell Lymphoma.

Authors:  R La Selva; S Alberti Violetti; C Delfino; V Grandi; S Cicchelli; C Tomasini; M T Fierro; E Berti; N Pimpinelli; P Quaglino
Journal:  Indian J Dermatol       Date:  2017 Mar-Apr       Impact factor: 1.494

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.